In fact, upregulation of SphK1 and its effector molecule S1P has been well established in various cancers and other human pathologies like pulmonary fibrosis, diabetes and Alzheimer’s disease. Here, SPHK1 is linked to early-onset autosomal dominant Alzheimer disease.